Novel experimental and clinical therapeutic uses of low-molecular-weight heparin/protamine microparticles

Area of Science:

• Biomaterials Science
• Cell Biology
• Biotechnology

Background:

• Low-molecular-weight heparin/protamine microparticles (LMW-H/P MPs) are developed as advanced carriers.
• These microparticles are designed to encapsulate heparin-binding growth factors (GFs) and facilitate cell adhesion.

Purpose of the Study:

• To investigate the efficacy of LMW-H/P MPs as a delivery system for GFs and cells.
• To evaluate the potential of LMW-H/P MPs as a biomaterial coating for cell culture and tissue engineering.

Main Methods:

• Production of LMW-H/P MPs by mixing low-molecular-weight heparin and protamine at a 7:3 volume ratio.
• Characterization of microparticle size (0.5-3 µm) and assessment of their binding capabilities to cells and tissue culture plates.
• Evaluation of GF immobilization, controlled release, and activity preservation.
• Assessment of cell viability and aggregate formation upon interaction with LMW-H/P MPs.

Main Results:

• LMW-H/P MPs effectively immobilize, control the release, and protect the activity of GFs.
• Microparticles promote cellular viability through aggregate formation and cell surface binding.
• LMW-H/P MPs demonstrate efficient binding to tissue culture plates, retaining GF binding, including fibroblast growth factor-2 (FGF-2).

Conclusions:

• LMW-H/P MPs serve as an excellent carrier for GFs and various cell types.
• The microparticle-coated matrix offers a novel biomaterial for controlling cellular activities like growth and differentiation.
• LMW-H/P MPs are efficient for cell culture applications, enhancing cell adhesion and viability.